ISM-0676

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameISM-0676
Drug Alias NameISM-0676ISM0676
ClassificationSmall molecules
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor antagonists
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Heart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInsilico Medicine Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Heart Failure
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A